# Exploring the interplay between kidney function and urinary metabolites in young adults: the African-PREDICT study

**Authors:** Wessel L. du Toit, Ruan Kruger, Lebo F. Gafane-Matemane, Aletta E. Schutte, Roan Louw, Catharina M. C. Mels

PMC · DOI: 10.1007/s00726-024-03412-7 · Amino Acids · 2024-08-29

## TL;DR

This study explores how kidney function relates to urinary metabolites in young adults with cardiovascular disease risk factors.

## Contribution

It identifies specific metabolites associated with kidney function in young adults with and without cardiovascular risk factors.

## Key findings

- Lower eGFR was observed in groups with cardiovascular risk factors compared to controls.
- eGFR was positively associated with various amino acids and carnitines in risk groups.
- Findings suggest altered metabolic regulation in response to cardiovascular risk factors.

## Abstract

The exposure to modifiable risk factors at young ages have been linked to premature fatal and non-fatal cardiovascular and kidney outcomes. The use of urinary metabolomics has shown strong predictability of kidney function and cardiovascular disease (CVD). We therefore determined the associations between estimated glomerular filtration rate (eGFR) and urinary metabolites in young adults with and without CVD risk factors. Apparently healthy Black and White sexes were included (aged 20–30 years) and categorised by the presence or absence of risk factors, i.e., obesity, physical inactivity, smoking, excessive alcohol intake, masked hypertension, hyperglycemia, dyslipidemia and low socio-economic status, forming the CVD risk group (N = 1036), CVD risk clusters (i.e. presenting with 1 CVD risk factor (N = 344), 2 CVD risk factors (N = 360) and 3 + CVD risk factors (N = 332)) and the control group (N = 166). eGFR was calculated with CKD-EPI equations. A targeted metabolomics approach using liquid chromatography-tandem mass spectrometry was used to measure amino acids and acylcarnitines. Lower cystatin C-based eGFR were indicated in the CVD risk group, 2 and 3 + CVD risk clusters compared to the control group (all P ≤ 0.033). In the CVD risk group, eGFR associated positively with histidine, lysine, asparagine, glycine, serine, glutamine, dimethylglycine, threonine, alanine, creatine, cystine, methionine, tyrosine, pyroglutamic acid, leucine/isoleucine, aspartic acid, tryptophan, glutamic acid, free carnitine, acetylcarnitine, propionylcarnitine, isovalerylcarnitine, octanoylcarnitine and decanoylcarnitine (all P ≤ 0.044), with similar results found in the CVD risk clusters, particularly the 2 CVD risk cluster. eGFR was positively associated with metabolites linked to aromatic amino acid and branched-chain amino acid metabolism, energy metabolism and oxidative stress. These findings may indicate altered reabsorption of these metabolites or altered metabolic regulation to preserve renal health in the setting of CVD risk factors at this young age without established CVD.

The online version contains supplementary material available at 10.1007/s00726-024-03412-7.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995)

## Full-text entities

- **Diseases:** obesity (MESH:D009765), CVD (MESH:D002318), hypertension (MESH:D006973), hyperglycemia (MESH:D006943), dyslipidemia (MESH:D050171)
- **Chemicals:** glycine (MESH:D005998), branched-chain amino acid (MESH:D000597), asparagine (MESH:D001216), histidine (MESH:D006639), lysine (MESH:D008239), acylcarnitines (MESH:C116917), alcohol (MESH:D000438), glutamic acid (MESH:D018698), isoleucine (MESH:D007532), aromatic amino acid (MESH:D024322), creatine (MESH:D003401), free carnitine (-), isovalerylcarnitine (MESH:C027333), serine (MESH:D012694), methionine (MESH:D008715), pyroglutamic acid (MESH:D011761), acetylcarnitine (MESH:D000108), amino acids (MESH:D000596), threonine (MESH:D013912), dimethylglycine (MESH:C025138), decanoylcarnitine (MESH:C002893), aspartic acid (MESH:D001224), propionylcarnitine (MESH:C003223), tyrosine (MESH:D014443), tryptophan (MESH:D014364), octanoylcarnitine (MESH:C008698), cystine (MESH:D003553), leucine (MESH:D007930), glutamine (MESH:D005973), alanine (MESH:D000409)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11362211/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11362211/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11362211/full.md

---
Source: https://tomesphere.com/paper/PMC11362211